Canada sees HIV plant funds redirected to research

Millions of dollars once earmarked for a Canadian HIV vaccine-production facility now will be spent on research and preventing mother-to-child transmission of the virus, Health Minister Leona Aglukkaq has announced.  A partnership between the federal government and the Gates Foundation had set aside $88 million for a lab to produce pilot HIV vaccines, but the program was cancelled in February. That decision triggered controversy among scientists, as well as some harsh criticism from the companies that hoped to win the contract to build and operate it. Story

Suggested Articles

Transporting pharmaceutical products at <-60C for more than 96 hours has seemed an insurmountable challenge. TOWER’s solution has solved the problem.

Roche will spend $500 million for a new global manufacturing logistics hub in Canada that will eventually employ 500 workers in Ontario.

Fledgling Indiana CDMO Incog BioPharma Services is shelling out $60 million to get its first manufacturing facility off the ground.